The Drug Safety field continues to grow in complexity, with both clinical trial safety and post-marketing pharmacovigilance becoming more critical in the development and marketed use of biologics. Already taxed Drug Safety Departments are struggling to comply with increased Clinical and Post-Marketing safety reporting requirements not to mention more vigilant Risk Management expectations.
The professionals at Orbis Clinical have decades of experiences as leaders in Drug Safety and Risk Management. Our niche expertise has resulted in successful working relationships with the leading biopharmaceutical companies worldwide.
Strategic:
Regulatory Response
Drug Safety Physician Practice
Assessment
End-to-End Consulting Engagements
Resource/Solution Development
Project Management
Insourcing
Outsourcing
Tactical:
Project Team Development
Staff Augmentation
Permanent Placement
Orbis Clinical - 781.569.0607 - info@OrbisClinical.com